Biobanking 2019

DESCRIPTION

On 14 & 15 February 2019, EPM Group will host the BioTech Pharma Summit: Biobanking 2019 in Porto, Portugal. This year event will bring together the world’s leading experts in biorepositories, policy makers, and scientific actors to strengthen knowledge in biobanking as well as explore future advances in the field of biosampling for precision medicine, drug development and health research.

The biobanking market is expected to reach USD 2.69 Billion by 2022 from USD 1.72 Billion in 2016 at a CAGR of 7.8%. Learn the current market trends and future challenges only at the Biobanking 2019

Our distinguished panel includes renowned clinicians, researchers, executives and technical professionals from the biopreservation industry as well as the pioneers for a worldwide human research resource. Moreover, the current era is flooded with new advanced technologies, which culminated with the proliferation of more Biobank institutes globally, acting as a clear indicator of a market growth in the field.

Geographically, the EMEA region is estimated to account for a market share of approximately 44% during the predicted period. The presence of a well-established biobanking system in the Nordic countries, such as Sweden, Norway, Denmark, Finland, and Iceland, is a significant factor that bolsters market growth in this region. This conference will gather biobanking leaders from the north, as well as from across the Atlantic, in order to zoom in the market prospects and understand the dynamics of this fast-paced growing industry.

Over 20 presentations and case studies focusing on the key areas of the biobanking industry including market access strategies, clinical development, commercialization, biostorage and biosampling-analytics at the Biobanking 2019

The BioTech Pharma Summit: Biobanking 2019 is the leading event to get through  the biobanking’s ever-thriving market and convenes key stakeholders from the field,  and innovator pharmaceutical manufacturers, payers, providers and patient advocates addressing timely challenges and best practices for biobanking product success.

We invite all the participants across the globe to join our scientific gathering in Porto, which aims to reveal the newest data and share innovative ideas from research area of bioengeneering and tissue preservation.

KEY PRACTICAL LEARNING POINTS

  • Present different types of biobanking and innovative models in precision medicine
  • Understand the opportunities and challenges of biosampling
  • Learn the latest technological methods and procedures for biopreservation, storage stability and validation, while naming evidence-based best practices
  • Explore new sample quality management systems, quality standards and accreditation
  • Learn how to maintain a sustainable infrastructure in biobanking
  • Debate the social and ethical challenges of biobanking for human research
  • Predict the market impact of biobanking in the next decade
  • Current market trends and future challenges for biobanking success
  • Biobanking development in emerging markets
  • Prognosis for the Global Biobanking market in an era of transformative new technologies
  • Commercial challenges and opportunities
  • Redesigning the biobanking business model
  • Clinical Trial Strategies in Biobanking and Drug Development
  • Determining the right investments & potential returns from Biobanks

WHO SHOULD ATTEND?

The BioTech Pharma Summit: (EPM Group) are exclusive events designed for senior level attendees from leading pharmaceutical, biopharmaceutical, biotechnology, diagnostics, CRO and solution provider companies, along with highly esteemed members of academic and government institutions. Chief Executives, Executive Directors, Vice Presidents, Heads and Team Leaders and Managers including:

  • Biobanking Researchers
  • Biobanking Faculty Members
  • Medical Colleges
  • Biobanking Associations and Societies
  • Training Institutes
  • Cryo storage Companies
  • Data Provacy and Management Companies
  • Security Officers
  • Global Biobanking Companies
  • Business Developers
  • Biobanking investors
  • Lab Managers
  • Biopharmaceuticals and Biologics Researchers
  • Molecular Technologies
  • Intellectual property
  • Legislation and Policy Advice
  • Legislation and Policy Advice
  • Drug and Safety Assessment
  • Market Strategy
  • Biopharmaceuticals
  • Chief Scientific Officer
  • Clinical Immunology
  • Drug Safety Assessment & Risk Management
  • Population and Disease Based biobanks
  • Bioinnovation
  • Intellectual property
  • Regulatory Affairs
  • Health Economics
  • Principal Scientists
  • Process Control and Analytical Technologies
  • Quality Affairs/ Quality Control
  • Regulatory Affairs
  • Regulatory Compliance
  • Legal Affairs
  • R & D
  • New Product Development
  • Quality Affairs/Quality Control
  • Health Economics
  • Process Control and Analytical Technologies

TICKET FEES

Individual Registration

Ticket FeesSuper Early bird*Early Bird*Discounted TicketNormal Ticket
Due DateUntil Oct. 19thUntil Nov. 30thUntil Jan. 10thAfter Jan. 10th
Industry Fee1495 Euros1695 Euros1795 Euros1995 Euros
Academic/Investor/NPO500 Euros600 Euros650 Euros850 Euros
Premium Package2800 Euros3000 Euros3250 Euros3550 Euros

*The Biobanking 2019 is an exclusive limited seat event. Super Early-Bird/Early bird tickets are non-refundable and subject to availability.

Group Registration:

Team DiscountsUntil October 19thUntil November 30thUntil January 10thAfter January 10th
2 Delegates10%5%----
3 Delegates15%10%5%--
4+ Delegates20%15%10%5%

Use the Coupon Code below and save your seat


Coupon CodesAcademic/NPO/InvestorIndustry FeePremium Package
Super Early BirdExpiredExpiredExpired
Early BirdACBI19INDB19PXBI18
Discounted TicketNot AvailableNot AvailableNot Available

*For Group registration or Sponsorship/Exhibition enquires, please use the contact form below.

Senior professor at the Karolinska Institutet, SE
Chief Scientific Officer at Coriell Institute for Medical Research, US
Project Manager at MRC HGU, University of Edinburgh, UK
Biobank Consortia & Communications at Trans-Hit Biomarkers, UK
Biobank and Model Bank Director at ARC-NET: Centre for Applied Research on Cancer, IT
Production Manager at NIBSC, UK
Editor-in-Chief, Biopreservation & Biobanking, US
Director, Head of Clinical Trials Biosample Mgmt. at Merck KGaA, DE
Manager at University Health Network, CA
Managing Director at Biostór Ireland, IE
Clinical Trial Biosample Manager at Merck KGaA, DE
CEO at BioKryo GmbH, DE
Marybeth Joshi
Director, Biobank & Translational Research Core at Duke University Medical Center, US
Executive manager at Biobank AS, NO
Ali Ismail
Founder & Managing Director at Birka Biostorage, SE
Chief Operating Officer at Biobank Graz, AT
Head of the LIFE-Biobank and Preanalytical Laboratory at University Hospital Leipzig, DE
Project Manager at Auria Biobank, FI
Managing Director of Biothéque Wallonie Bruxelles, BE
Svetlana Gramatiuk
President and Medical Director at Ukraine Association of Biobank, UA
Industry Package
1,995
Buy Ticket

Full access to Presentations

Full access to Networking sessions

One-on-One Meetings

Business Lunches

Premium Package
3,550
Buy Ticket

Full Access to Both Streams: Biobanking + CDx & Biomarkers

VIP Airport Pick-Up

One-on-One Meetings

Accommodation in Superior Room

Academic Package
850
Buy Ticket

Full access to Presentations

Full access to Networking sessions

Business Lunches

Exhibition Package
3,550
Buy Ticket

3m2 Exhibition Space

Full Access to Industry Package

Book Bag Inserts

Gala Dinner